fda tirzepatide shortage resolved october 2 2024 GLP-1 Drugs: Removes Lilly's Zepbound® and Mounjaro® (tirzepatide injection) from its Drug List FDA Affirms Decision on Tirzepatide

If a sponsor wants to focus on muscle volume assessments, MRI offers more muscle-related endpoints, while DXA can assess fat and lean mass parameters

The first reason is supply shortages which have left many patients unable to fill their prescriptions

PlexusDx offers compounded tirzepatide injections at $289/mo month-to-month, or from $249/mo on the 6-month plan and GLP-Squared Injection (dual semaglutide and tirzepatide) at $289/mo month-to-month, or from $249/mo on the 6-month plan, allowing providers to optimize therapy based on individual trajectory

More research is needed to learn how GLP-1 agonists like semaglutide may affect inflammation in UC